Skip to content

Placement of Nasogastric Tubes for Gastric Decompression in Patients With Bronchiolitis

Placement of Nasogastric Tubes for Gastric Decompression in Patients With Bronchiolitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04480970
Enrollment
60
Registered
2020-07-22
Start date
2020-08-03
Completion date
2025-07-01
Last updated
2023-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis

Brief summary

This study aims to evaluate whether placing nasogastric tubes for gastric decompression improves respiratory distress for patients with bronchiolitis who are receiving oxygen via high-flow nasal cannula.

Detailed description

All patients will be consented per IRB procedure. The study will be a prospective study. Study participants will be enrolled after placement on high flow nasal cannula. The respiratory therapist or study staff will use a bronchiolitis scoring tool, the Marlais Risk of Admission Score, to assess the respiratory status of patients after placement on high flow nasal cannula, and prior to placement of NG tube to establish a baseline measurement. This tool includes the following components: respiratory rate, oxygen saturation, heart rate, age, and length of illness. An NG tube will then be placed. Thirty minutes and sixty minutes after placement of the NG tube, the respiratory therapist or study team will again use this scoring tool to assess the respiratory status of the patient. After 60 minutes the study will be concluded. As subject will be requiring oxygen use, admission to an inpatient unit is required. The NG tube will be removed at the discretion of the provider or the admitting physician, who may choose to keep it in at their discretion.

Interventions

All patients enrolled in the study will have a nasogastric tube placed for gastric decompression.

Sponsors

Arkansas Children's Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 23 Months
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of bronchiolitis by the attending physician * On high flow nasal cannula (4 liters or greater) * Ages 0 months to 23 months

Exclusion criteria

* Diagnosis of bacterial pneumonia * History of cranio-facial anomalies * History of congenital heart disease * History of G-tube dependence * History of short gut syndrome * History of tracheostomy or current tracheostomy

Design outcomes

Primary

MeasureTime frameDescription
Respiratory status60 minutesA bronchiolitis scoring tool, the Marlais Risk of Admission Score, will be used to assess the respiratory status of patients. This tool includes the following components: respiratory rate, oxygen saturation, heart rate, age, and length of illness.

Countries

United States

Contacts

Primary ContactLeroy Crawley, MS
crawleylj@archildrens.org5013643481

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026